Becton Dickinson & Co.

0R19 London Stock Exchange Healthcare & Biotech United States
1.71 £
1.08 %

American company specializing in the design, manufacture, and sale of medical devices, instruments, and reagents used in healthcare and medical research.

Performance & Momentum

6 Months 15.37 %
1 Year 0.26 %
3 Years 2.55 %
5 Years 2.23 %

Strategic Analysis

Becton Dickinson is a leading player in medical devices and diagnostic/laboratory tools, with significant exposure to the recurring needs of hospitals, laboratories, and research. Its positioning is built on essential products embedded in healthcare workflows, giving it a defensive profile and strong long-term structural visibility.

Strengths
  • Portfolio of essential medical and laboratory products, supported by structurally stable, non-cyclical demand
  • Strong presence in niches with high barriers to entry, backed by a loyal institutional customer base
  • Defensive healthcare sector profile, supportive of recurring revenues
Weaknesses
  • Share price trend remains uneven over medium-term horizons, suggesting incomplete market confidence
  • Exposure to cost pressures, regulatory constraints, and margin sensitivity in medical devices
Momentum

Momentum is moderately positive, with recent improvement contrasting with a more hesitant stock-market history over the past few years. This suggests renewed investor interest in a high-quality defensive profile, but without a sufficiently clear acceleration to point to a true regime shift.

Similar stocks to Becton Dickinson & Co.

Anantys Community

Be the first to share your analysis on Becton Dickinson & Co..

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases